Published in Vaccine Weekly, March 3rd, 2010
The oral presentation, "Preclinical Studies on DNA/MVA Vaccines: Co-expressed GM-CSF, a Strong Adjuvant for Prevention of Infection," was presented by Dr. Harriet Robinson, Chief Scientific Officer for GeoVax and developer of the Company's vaccines. The study investigated the use of GM-CSF...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly